Dermapharm Holding SE annual shareholders’ equity
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Dermapharm Holding SE Shareholders’ Equity Growth & History (DMP)
Dermapharm Holding SE's shareholders’ equity was €694.4M for fiscal 2025.
View full Dermapharm Holding SE company overviewDermapharm Holding SE annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €694.4M | €90.0M | +14.88% |
| 2024 | 2024-12-31 | €604.4M | €65.2M | +12.09% |
| 2023 | 2023-12-31 | €539.2M | €7.6M | +1.43% |
| 2022 | 2022-12-31 | €531.6M | €34.3M | +6.89% |
| 2021 | 2021-12-31 | €497.3M | €175.3M | +54.46% |
| 2020 | 2020-12-31 | €322.0M | €43.3M | +15.55% |
| 2019 | 2019-12-31 | €278.6M | €26.2M | +10.38% |
| 2018 | 2018-12-31 | €252.4M | €178.8M | +242.63% |
| 2017 | 2017-12-31 | €73.7M | €16.8M | +29.44% |
| 2016 | 2016-12-31 | €56.9M | €15.8M | +38.49% |
| 2015 | 2015-12-31 | €41.1M | €12.8M | +45.33% |
| 2014 | 2014-12-31 | €28.3M | — | — |
Dermapharm Holding SE quarterly shareholders’ equity
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €536.7M | −€71.5M | −11.76% |
| Q1 2026 | 2026-03-31 | €738.9M | €100.3M | +15.71% |
| Q4 2025 | 2025-12-31 | €694.4M | — | — |
| Q3 2025 | 2025-09-30 | €649.2M | — | — |
| Q2 2025 | 2025-06-30 | €608.2M | — | — |
| Q1 2025 | 2025-03-31 | €638.6M | — | — |
Dermapharm Holding SE shareholders’ equity trends
Over the last five fiscal years, Dermapharm Holding SE's shareholders’ equity increased from €322.0M to €694.4M, a change of €372.4M. The latest reported quarter, Q2 2026, shows €536.7M.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company official filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dermapharm Holding SE source filings ↗